Such metabolic imbalance in RA is caused by chronic inflammation with elevated levels of wasting cytokines including tumor necrosis factor (TNF)-α, therefore potent anti-rheumatic therapy using DMARDs may improve the imbalance at least to some extent (6, 7). The gene discussed is TNF; the disease is rheumatoid arthritis.